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Structural Basis for Human PECAM-
1-Mediated Trans-homophilic Cell 
Adhesion
Menglong Hu1, Hongmin Zhang2, Qun Liu3 & Quan Hao1
Cell adhesion involved in signal transduction, tissue integrity and pathogen infection is mainly 
mediated by cell adhesion molecules (CAM). One CAM member, platelet–endothelial-cell adhesion 
molecule-1 (PECAM-1), plays an important role in tight junction among endothelia cells, leukocyte 
trafficking, and immune response through its homophilic and heterophilic binding patterns. Both 
kinds of interactions, which lead to endogenous and exogenous signal transmission, are derived 
from extracellular immunoglobulin-like (IgL) domains and cytoplasmic immunoreceptor tyrosine-
based inhibitory motifs (ITIMs) of PECAM-1. To date, the mechanism of trans-homophilic interaction 
of PECAM-1 remains unclear. Here, we present the crystal structure of PECAM-1 IgL1-2 trans-homo 
dimer. Both IgL 1 and 2 adopt the classical Ig domain conformation comprised of two layers of β-sheets 
possessing antiparallel β-strands with each being anchored by a pair of cysteines forming a disulfide 
bond. The dimer interface includes hydrophobic and hydrophilic interactions. The Small-Angle X-ray 
Scattering (SAXS) envelope of PECAM-1 IgL1-6 supported such a dimer formation in solution. Cell 
adhesion assays on wildtype and mutant PECAM-1 further characterized the structural determinants in 
cell junction and communication.
Platelet–endothelial-cell adhesion molecule-1 (PECAM-1), also well known as CD31, is a 130 kilodalton protein 
which belongs to both type I transmembrane glycoprotein and immunoglobulin (Ig) superfamily1. PECAM-1 can 
be divided into three parts: extracellular region which contains six immunoglobulin-like (IgL) domains with nine 
potential N-glycosylation sites, transmembrane region with one single α helix, and cytoplasmic region which 
possesses two separate tyrosine residues (Y663 and Y686) described as immunoreceptor tyrosine-based inhibi-
tory motifs (ITIMs)2,3. Its distribution primarily concentrates on endothelial cells and platelets1,3. Furthermore, 
PECAM-1 is also expressed by those cells responsible for innate immunity, such as monocytes, neutrophils, and 
natural killer cells, and for adaptive immunity B and T cells4–8. In addition, it can be expressed either by dendritic 
cells acting as antigen presenting cells or by certain vascular tumor cells3,9.
As a cell adhesion molecule, PECAM-1 functions principally in cell junction but also plays a role in leukocyte 
trafficking and immune response2,10,11. Among adjacent endothelial cells, PECAM-1 interacts with homogeneous 
molecules in a trans-homophilic binding manner that does not rely on transmembrane and cytoplasmic regions. 
This kind of homophilic interaction can be interrupted efficaciously by IgL1 and IgL1–2 antibodies both in vivo 
and in vitro12,13. The homo-binding pattern leads to phosphorylation on Y663 and Y686 which triggers tertiary 
complex formation consisting of PECAM-1/SHP-2/β -catenin14. Phosphorylated ITIMs recruit SHP-2 which 
will further dephosphorylate β -catenin. Subsequently, β -catenin re-associates with another adhesion molecule 
VE-cadherin to stabilize cell junction15–17. In addition to its positive feedback, the PECAM-1 homophilic binding 
intensifies cell junction and gives rise to a tight barrier of endothelium. In the course of diapedesis inclusive of 
homo- and hetero- interactions of PECAM-1, its crosstalk with integrin α vβ 3 establishes adhesion between leuko-
cyte and endothelia cells as well as association between cell adhesion molecules and integrins including VCAM-1/
α 4 and ICAM/β 218–20. Moreover, PECAM-1 could associate with CD38 on lymphocytes and CD177 on neutro-
phils and may work in the regulation of diapedesis according to previous studies21,22. In contrast, PECAM-1 
homophilic interactions can stimulate formation of lateral border recycling compartment (LBRC) in endothelial 
cells to promote transmigration of leukocytes23. Meanwhile, between naïve T-cells and antigen presenting cells, 
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PECAM-1 homophilic interaction mediated phosphorylation on ITIMs trigger ERK1/2 downstream signal path-
ways via SHP-2 recruitment followed by gene transcription for cell survival, resulting in enhanced tolerance of 
naïve T-cells9. Furthermore, PECAM-1 can interplay with Plasmodium falciparum erythrocyte membrane protein 
1 (PfEMP-1) expressed by Plasmodium falciparum infected red blood cells, which could potentially accelerate 
infected cell aggregation in blood vessels24,25.
Although numerous important physiological functions of PECAM-1 root in homophilic and hetero-
philic interactions on its extracellular six IgL domains, little molecular mechanism is known except the recent 
reported IgL1–2 structure by Zhu and co-workers26. However, this structure was a cis-dimer in one asymmetric 
unit with the IgL2 “fold-out” as opposed to classical immunoglobulin. Here, we report a crystal structure of 
trans-homophilic IgL1-2 dimer to reveal the binding pattern of the IgL1-2 homo-interactions and to provide 
mechanistic understanding of IgL1-2 in cell adhesion.
Results
Structure determination. The extracellular portions of PECAM-1 on adjacent cell surfaces show a homo-
philic binding pattern, which contributes to tight cell junction and builds a barrier between basal lamina and 
blood vessel together with other cell adhesion molecules12,13. Previous studies have demonstrated that the first 
two IgL domains of PECAM-1 were involved in the homophilic interaction. Therefore, we chose the fragment 
spanning residues 28-232 (IgL1-2) for crystallographic study. To avoid the uncontrolled glycosylation in insect 
cell expression system that might impair crystallization, we mutated three potential glyco-sites on IgL1-2 (N52Q, 
N84Q and N151Q). Then we expressed, crystallized this mutant IgL1-2 and obtained the native diffraction data 
set. However, we could not solve the phase problem by using existing immunoglobulin structures as search mod-
els despite high similarity among immunoglobulin superfamily members. Thus, IgL1-2 was split into individual 
IgL1 and IgL2 spanning residues 28-132 and 133-232 respectively. These two small fragments were expressed in 
Escherichia coli. We crystallized both native and Se-Met IgL1 fragments and collected diffraction data sets of high 
resolution at 2.0 Å. The experimental phases of the SeMet IgL1 data set were determined by single-wavelength 
anomalous dispersion (SAD) method27. Based on the partial structural model of IgL1, we used molecular replace-
ment and then several cycles of manual model rebuilding and refinement to phase the native IgL1-2 data set. The 
whole structure of IgL1-2 was finally determined to 3.0 Å resolution where one asymmetric unit contains two 
IgL1-2 molecules (chains A and B) forming a dimer (Fig. 1A).
Overall structure. The homodimer of PECAM-1 IgL1-2 displays a trans-binding pattern that relies on the 
interactions between IgL1 and IgL2 derived from two opposite molecules. Both IgL1 and IgL2 are highly similar 
to each other and their conformations belong to the classical architecture of immunoglobulin. Each of them 
is composed of two parallel β sheet layers anchored by a pair of cysteine residues (Cys57, 109 and Cys152, 206 
on IgL1 and 2 respectively) which form a disulfide bond whereby every β sheet layer contains 3-5 antiparallel β 
strands. Moreover, a short α helix (residues 100-103) of unknown function links the 7th and 8th β strands of IgL1.
Figure 1. Overall structure of PECAM-1 IgL1-2 trans-homophilic dimer. (A) Front and back views of the 
IgL1-2 trans-homophilic dimer structure in which IgL1 and IgL2 are labeled with blue and red colors respectively. 
IgL1 interacts with IgL2 from the opposite monomer. Both IgL1 and IgL2 hold a traditional immunoglobulin 
conformation that consists of two β -sheet layers anchored by one disulfide bond. (B) Hydrophobic and hydrophilic 
surface of an IgL1-2 monomer. Hydrophobicity surfaces are presented by Chimera with orange red for most 
hydrophobic and dodger blue for most hydrophilic33. The two interface regions of the IgL1-2 dimerization are 
highlighted by two black ellipses. Hydrophobic areas are concentrated at the center of each region and hydrophilic 
areas form two circumambient barriers that surround hydrophobic centers.
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Homophilic adhesion interface. As shown in Fig. 1, the two IgL1-2 fragments are packed to each other 
in a face-to-face antiparallel pattern with the side face of one β sheet. There are two interacting surfaces, one 
between IgL1 of chain A (IgL1-A) and IgL2 of chain B (IgL2-B) and the other between IgL2 of chain A (IgL2-A) 
and IgL1 of chain B (IgL1-B). After analyzing the interaction surface of IgL1-2 dimer (Fig. 1B), the solvent acces-
sible areas buried in interfaces on chain A and B are 1079.0 Å2 and 1094.2 Å2 respectively, and there are two types 
of reciprocities consisting of hydrophobic interaction and hydrogen bond. Although the overall conformation 
of the two interfaces is almost identical, there are subtle differences between them. On one hand, there are two 
hydrophobic interaction surfaces and each of them is located between the vis-à-vis IgL1 and IgL2 from opposite 
molecules (Fig. 2A). The two hydrophobic centers are mainly composed of nonpolar residues with participation 
of several C and O atoms on surrounding polar residues. On interface1 (IgL2-A-IgL1-B), residues including K158, 
N187, F188 from IgL2-A and L74, L81, E117 from IgL1-B form the core of the hydrophobic interactions, while 
N115 from IgL1-B forms satellite hydrophobic interactions with I190, R149 from IgL2-A by donating C and O 
atoms on backbone to reinforce the hydrophobic contact. Similarly, interface2 (IgL1A-IgL2-B) residues including 
L74, I112, K116 from IgL1-A and R149, P155, F188, I190 from IgL2-B form the hydrophobic center while the 
C/O atoms from N115, Q84 on IgL2-A and N187 on IgL1-B form satellite hydrophobic interactions. Among 
those residues, L74, I112, F188 and I190 were proven to affect the intermolecular binding pattern of PECAM-1 
in vivo by our mutational analysis described below. On the other hand, twelve pairs of residues form hydrogen 
bonds with donor-acceptor distances of 2.56-3.77 Å (Fig. 2B and C). On IgL1-A, Q72, L81, Q84, N114 and N115 
form hydrogen bonds with Q151, K158, N187, D138 and T136/R149/Q151 on IgL2-B respectively (Fig. 2B). 
Meanwhile, N114, N115 and E117 on IgL1-B interplay with D138, T136/R149/Q151 and Q186 on IgL2-A respec-
tively (Fig. 2C). Since we mutated N52, N84, and N151 residues to Q to eliminate glycosylation and the side chain 
of N is shorter than Q, there are eight hydrogen bonds expected with donor-acceptor distances of 2.71–3.77 Å. 
after excluding four resulted from mutated residues. Thus, the hydrophobic binding core surrounded by hydrogen 
bonds gives rise to the homophilic dimerization of IgL1-2.
SAXS verification of PECAM-1 trans-homophilic binding pattern. To eliminate crystal packing arti-
fact of IgL1-2, wild type full length extracellular domain of PECAM-1 (IgL1-6), which contains nine potential 
glycosylation sites, was expressed in the same insect cell system that produced IgL1-2. Then we measured the 
molecular conformation via Small-Angle X-ray Scattering (SAXS) in a similar manner as reported28 in order to 
Figure 2. Interfaces of IgL1-2 dimerization. (A) Residues that participate in homophilic interaction are 
plotted and displayed in 2D with DIMPLOT of the LigPlot plus suite35. Protein side chains primarily involved 
in hydrophilic interaction are shown as ball-and-stick. Red, blue, black balls represent oxygen, nitrogen and 
carbon atoms respectively. Green dotted lines labeled with distances indicate hydrogen bonds. Non-bonded 
residues contributing to hydrophobic interactions are shown as spoked arcs. Oxford-blue dotted lines embrace 
residues located at the same IgL domains. Interface2 (in between IgL2-B and IgL1-A) and Interface1 (in between 
IgL1-B and IgL2-A) correspond to (B) and (C) revealing 3D representation of hydrogen bonds processed by 
Chimera. Chain A and B are colored in corn flower blue and hot pink respectively. O (red) and N (blue) atoms 
that contribute to hydrogen bonds are linked by dotted lines (dark blue) with distance labels.
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verify the trans-homophilic dimerization of PECAM-1 in solution. Data analysis yielded a linear Guinier curve 
and a distance distribution indicating a rod-like shape (Sup Fig. 1A,B).
Low resolution envelope was generated based on the bead model calculated from SAXS data. The scattering 
from the bead model was consistent with experimental intensities (Fig. 3A). The calculated envelope had ade-
quate space to fit in two IgL1-6 molecules. The elongated envelope consisted of a large center that appeared to 
be an interaction region and two slender outstretched arms representing dissociative parts (Fig. 3B). Moreover, 
the envelope can be well fitted using the crystal structure of one PECAM-1 IgL1-2 dimer solved in this study for 
the central part and eight single IgL1 (to fit the IgL3-6 region where the crystal structure is unavailable) for the 
outstretched part. The SAXS model of PECAM-1 demonstrated that two PECAM-1 IgL1-6 molecules could form 
a trans-homophilic dimer in solution, which further validated the interaction of IgL1-2 determined in our crystal 
structure. Compared to IgL1-2, which can form a homo-dimer, IgL3-6 is much more flexible due to the absence 
of transmembrane and cytoplasmic portions which can anchor IgL3-6 on cell membrane.
Cell adhesion is independent of glycosylation on IgL1-2. PECAM-1 is a glycoprotein with nine 
potential glyco-sites on six IgL domains in which three of them localize on IgL1-2 with N52, N84 on IgL1 and 
N151 on IgL2. On account of differences between insect and mammalian cell protein expression systems, we used 
human derived HEK293 cell line to mimic the original expression environment of PECAM-1. For a full-length 
PECAM-1 glycosylation mutation sample, we mutated the same three sites in the IgL1-2 fragment as that chosen 
for structural study. Meanwhile, for a functional mutation sample, four residues (L74, I112, F188 and I190) situ-
ated in the hydrophobic center identified in our crystal structure were mutated to E to disrupt the intermolecular 
binding of PECAM-1. Then we inserted wildtype and mutated DNA sequences into mammalian transient expres-
sion vector and transfected into HEK293 cell line for cell adhesion assay. Transfected cell line would express full 
length PECAM-1 linked with C-terminal 3*FLAG tags derived from vector, and we used FLAG tag antibody to 
detect target protein expression. The principle of cell adhesion assay is based on PECAM-1’ s ability to promote 
cell junction. Experimental subjects contain four groups: negative control (NeCon), wildtype (WT), glycosylation 
mutation (GlycoM) and functional mutation (FunM) groups constituted by cell lines transfected with empty, 
wildtype, glyco-mutated and functional mutated PECAM-1 vectors respectively. Each group was split into two 
equal portions. For labelling cell membrane, one portion was incubated with PKH26 red fluorescent cell linker, 
and the other incubated with PKH67 green fluorescent cell linker. We then mixed the two together in equal pro-
portions and incubated them at 37 degrees for 30 mins. During the incubation, cell adhesion would happen. After 
that, we used flow cytometry to detect the percentage of cell adhesion between PKH26- and PKH67-cells. After 
using unlabeled cells and single labeled cells for gating in flow cytometry, PE and FITC areas represent PKH26- 
and PKH67-cells respectively, whereby Unstain area shows unlabeled cells and Adhesion area represents the cell 
junction between two different labeled cells. We counted the cell quantity in Adhesion area and calculated its per-
centage for quantification. Through the results (Sup Fig. 2), we found that cells with two different labels contacted 
with each other in a higher proportion in both WT and GlycoM groups than in the NeCon and FunM groups 
(n = 4). Either wildtype or glyco-mutated PECAM-1 can increase cell adhesion two-fold in WT and GlycoM 
groups, compared with NeCon and FunM groups (Fig. 4). Mutations on three potential glyco-sites did not affect 
physiological function of PECAM-1 on cell membrane. Furthermore, four residues (L74, I112, F188 and I190) 
Figure 3. SAXS analysis of PECAM-1 IgL1-6 in solution. (A) The fitness between the scattering of calculated 
model (green curve) and experimental intensities (red curve with individual bar). (B) Low resolution envelope 
fitted with the crystal structures of IgL1-2 dimer and IgL1. Two different IgL1-6 molecules are in blue and red 
color respectively. Central part is assembled with an IgL1-2 trans-homodimer. Expanded arms with relative 
flexibility are fitted with eight IgL1 monomers.
www.nature.com/scientificreports/
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important for hydrophobic binding can effectively influence PECAM-1 derived cell conjunction. Mutations on 
these four sites can effectually reduce trans-homophilic adhesion between PECAM-1-overexpressing HEK293 
cells, which further certifies the homophilic binding interface of PECAM-1 IgL1-2 in vivo. Hence, with contribu-
tion of homophilic interaction of its IgL1-2, PECAM-1 derived cell adhesion is not glycosylation (N52, N84 and 
N151) related.
Discussion
PECAM-1 participates in the formation of a strong barrier with other adhesion molecules between blood vessel 
and basal lamina. It also functions as a regulator and cooperator in the leukocyte trafficking process through 
both homophilic and heterophilic interaction on its extracellular region containing six Ig-like domains. The first 
two Ig-like domains (IgL1-2) can dimerize in a trans-homophilic manner which still has not been characterized 
to date. As a result, our crystal structure of PECAM-1 IgL1-2 trans-homophilic dimer not only shows a detailed 
drawing of Ig-like domains but also elaborates on the dimerizing mechanism of IgL1-2. As domains in a member 
of the Ig-superfamily, IgL1 and IgL2 of PECAM-1 have folds highly resembling those of traditional Ig domains. 
Each domain can be described as a “sandwich” architecture built with two β -sheet layers interlinked by a disulfide 
bond. The two tandem Ig-like domains cooperate with another homo-molecule via hydrophobic interaction and 
hydrogen bonds to form a tight trans-dimer. This trans-homophilic interaction was validated by small-angle 
X-ray scattering data of full-length wild type extracellular domain of PECAM-1. According to the cell adhesion 
assay, PECAM-1 derived cell junction is not associated with glycosylation on the first three putative N-glyco sites, 
which is consistent with our crystal structure of IgL1-2 possessing interface where two potential but uncertain 
glyco-sites (N84 and N151) localize.
A recent study reported a crystal structure of selenomethionyl IgL1-2 cis-homophilic dimer resulting from 
a “bridge” contact constituted by the last two β strands on each IgL226. The last portion of IgL2 spanning residue 
214–228, which interplays with the 12th, 13th and 15th β strands in the same molecule to form one β -sheet layer 
in our crystal structure, dissociates from its own IgL2, swings out and inserts into the corresponding position 
of IgL2 of a neighboring molecule, forming cis-homophilic IgL2. Although interfaces among IgL1-2 molecules 
were also identified through crystallographic symmetric operations, they did not contribute much to the bind-
ing. No interface was found in one asymmetric unit except the “bridge” contact. In contrast, our structure shows 
trans-homophilic dimerization of native IgL1-2 in one asymmetric unit, and the last peptide chain 214–228 in 
IgL2 does not swing out from its own architecture (Sup Fig. 3).
In this work, we have demonstrated the trans-homo-interaction mechanism of PECAM-1 IgL1-2. However, to 
fully understand the homophilic interaction of PECAM-1 and its function in cell junctions, the structure of full 
length or whole extracellular region of PECAM-1 needs to be determined. Our structure provides insights into 
understanding these multiple functions of PECAM-1 in endothelium integrity, immune response, and diapedesis.
Data deposition. Coordinates and structure factors have been deposited in the protein data bank, under 
PDB code 5GNI.
Material and Methods
Vector cloning and mutagenesis. Plasmid that contained human PECAM-1 full length (FL, 1-738) DNA 
sequence was purchased from Addgene and IgL1-2 (28-232) DNA sequence suitable for insect cell expression 
Figure 4. Mutational analysis on PECAM-1 mediated cell adhesion. Compared to negative control (NeCon) 
group, both wildtype (WT) and glyco-mutated (GlycoM, N52Q/N84Q/N151Q) PECAM-1 can significantly 
increase cell junction among HEK293 cells. Functional mutation (FunM, L74E/I112E/F188E/I190E) on 
PECAM-1 can decrease the probability of cell contact. (**P < 0.005; ***P < 0.0005; ns: non-significant).
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with glyco-mutation (N52Q, N84Q and N151Q) was synthesized by GenScript. For recombinant protein expres-
sion, IgL1-6 (28–600) amplified by Polymerase Chain Reaction (PCR) from PECAM-1 FL DNA sequence and 
IgL1-2 digested from synthesized DNA sequence were cloned into pMib-V5-HisA vector (Invitrogen). IgL1 
(28-132) and IgL2 (133–232) were amplified from synthesized DNA sequence and inserted into pET22b vector 
(Novagen). For cell adhesion assay, human PECAM-1 FL without stop codon was cloned into pCMV-3Tag-3A 
vector. Based on wildtype pCMV-3Tag-3A-PECAM-1 FL vector, GlycoM vector with mutations (N52Q, N84Q 
and N151Q) was produced by Site Directed Mutagenesis method point by point and FunM vector with mutations 
(L74E, I112E, F188E and I190E) was synthesized by BGI. All constructed vectors were validated by sequencing 
at BGI.
Protein expression, purification and crystallization. For insect cell expression, pMib-V5-HisA vec-
tors containing PECAM-1 fragments were transfected into High Five cell lines. Stable cell lines expressing target 
proteins were selected by blasticidin. Cells were cultured in High Five Express media (Invitrogen). Suspension 
culture volume was enlarged under 27 degrees. After 9–10 days, insect cell culture was collected and centrifuged 
at 4000 rpm under 4 degrees for 1 hour for removing cell debris. Supernatant was loaded onto Ni-column (GE), 
and target proteins were eluted by buffers with gradient concentration of imidazole step by step. For the purifica-
tion of IgL1-6, eluted sample was concentrated directly and then loaded onto Superdex 75 column (GE). Target 
fractions were pooled and concentrated for SAXS. For IgL1-2, eluted sample was purified by ion-exchange (Q-HP, 
GE) and gel-filtration (Superdex 75, GE) columns. Target protein was concentrated for crystal screening based 
on commercial kits from Hampton Research. For E. coli cell expression, pET22b vectors with IgL1 and IgL2 were 
transfected into BL21 (DE3) Origami strain. Cells were cultured in 2*YT media and enlarged under 37 degrees. 
Protein expression was induced by 0.3 mM IPTG under 16 degrees for 18 hours. Cell culture was centrifuged 
at 4000 rpm under 4 degrees for 30 mins. After removing culture media, cell pellet was re-suspended in buffer 
(20 mM Tris-HCl pH = 8.0, 500 mM NaCl and 10 mM imidazole) and lysed by sonication. Lysed sample was spun 
down at at 17000 rpm under 4 degree for 30 mins. Similar to IgL1-2, IgL1 and IgL2 were purified and concentrated 
for Crystal screening. SeMet incorporation of IgL1 was performed as described previously. SeMet-IgL1 was puri-
fied in same way as native IgL1.
IgL1-2 (14 mg/ml), IgL1 (20 mg/ml) and IgL2 (18 mg/ml) were used for primary crystal screening through 
vapor diffusion method. We obtained IgL1-2 and IgL1 crystals but not IgL2. Crystal optimizations were based 
on best hits (0.1 M MES pH6.5/1.8 M (NH4)2SO4/0.01 M CoCl2 for IgL1-2 and 2.0 M (NH4)2SO4 for IgL1). IgL1-2 
single crystals were produced in conditions (0.1 M MES pH6.2–6.8/1.4–1.6 M (NH4)2SO4/0.01 M CoCl2) through 
seeding method. IgL1 single crystals grew in condition (1.6–1.8 M (NH4)2SO4). The single crystals of Se-Met-IgL1 
were harvested in the same conditions as native IgL1.
Data collection, processing and structure refinement. Crystals were frozen in liquid nitrogen with 
cryo-protection. Diffraction data sets were collected at 100 K on BL17U beamline in Shanghai Synchrotron 
Radiation Facility (SSRF) and processed by HKL200029. Phases of Se-Met-IgL1 data set were determined 
through single-wavelength anomalous dispersion (SAD) method with AutoSol in the Phenix program suite30. 
Data Collection
IgL1-2 IgL1
Cell dimensions 
 a, b, c (Å) 60.5, 141.5, 169.9 97.5, 97.5, 128.3
 α , β , γ (°) 90, 90, 90 90, 90, 90
Space group I222 P212121
Wavelength (Å) 1.0719 0.97980
Resolution (Å)a 50.00-3.00 (3.05- 3.00) 50.00-2.00 (2.07- 2.00)
Unique reflections 14823 (709) 82445 (7952)
Redundancy 7.9 (8.0) 14.6 (13.0)
< I /σ I> 25.12 (3.07) 28.91 (14.82)
Rsym 0.086 (0.838) 0.096 (0.187)
Completeness (%) 99.7 (100.0) 99.60 (97.03)
Refinement
Rwork 0.22
Rfree 0.28
RMSD from ideal
 Bond lengths (Å) 0.01
 Bond angles (°) 1.35
Average B-factors 64.4
Ramachandran plot (%):
favored/allowed/outliers 94.0/6.20/0.26
Table 1.  Crystallographic Data and Refinement Statistics. aValues in parentheses are from the highest-
resolution shell.
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Model rebuilding was carried out by AutoBuild in Phenix program suite30. We then used the partial structure of 
Se-Met-IgL1 as a search model for molecular replacement on the IgL1-2 data sets with Phaser in the CCP4 pro-
gram suite31. Subsequently, we manually rebuilt IgL1-2 model in COOT followed by refinement via the Phenix_
refine program30. After many rebuilding-refinement cycles, we obtained the crystal structure of IgL1-2. Table 1 
shows the crystallographic statistics of IgL1-2 and IgL1 data sets.
Small-angle X-ray scattering. Purified PECAM-1 IgL1-6 and purification buffer that acted as target sam-
ple and solution background respectively were taken to SSRF for SAXS data collection on BL19U2 Bio-SAXS 
beamline. Collected image data was converted to.dat file by BioXTAS RAW software32. Further data processing, 
averaging and subtracting were accomplished by Primus in the ATSAS program package33. After determining the 
linear Guinier region and distance distribution to obtain extrapolated I0 and reasonable Dmax respectively, bead 
modeling was carried out in slow mode with Damif called by Primus. The mesh envelope of final solution was 
represented by Chimera and fitted with the crystal structure of IgL1-2 and IgL134.
Cell adhesion assay. pCMV-3Tag-3A empty and PECAM-1 FL genes (WT, GlycoM and FunM) inserted 
vectors were transfected into HEK293 cell lines cultured in 10 cm dishes. Cells with overexpression of exogenous 
proteins were collected in two days. After removing culture media through centrifugation, cells was washed with 
PBS two times for eliminating residual FBS and then resuspended in 200 ul Dilute C buffer (SIGMA). Cell suspen-
sion was divided into two parts with same volume (100 ul). At the same time, 2 ul PKH67 green and 2 ul PKH26 
red fluorescent cell linkers were diluted in 100 ul Dilute C buffer respectively. Then two homologous cell suspen-
sions were mixed with cell linkers diluents and incubated in dark at room temperature for 5 mins followed by 
adding equal volume of FBS for terminating cell label processes. Centrifugation was performed under 4 degrees at 
300 g for 5 mins. Labeled cells were collected and washed by PBS one time. Next, labeled cells were re-suspended 
by 300 ul PBS and counted. We mixed two equal amounts of labeled cells and incubated them in waterbath under 
37 degrees for 30 mins. Adhered, unstained and single stained cells were analyzed by flow cytometry. FACS data 
sets were analyzed by FlowJo software.
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